A 58-year-old man from Delhi presents with a 2 cm dark nodule on his back that has grown rapidly over 3 months. Biopsy shows melanoma with 4 mm Breslow thickness, brisk lymphocytic infiltration, and no ulceration. All of the following are accurate prognostic indicators in this case EXCEPT:

Explanation

## Prognostic Factors in Cutaneous Melanoma ### Major Prognostic Factors (AJCC 8th Edition) | Factor | Prognostic Impact | Details | | --- | --- | --- | | **Breslow Thickness** | Most important overall | <1 mm: ~95% 5-yr survival; 1–2 mm: ~90%; 2–4 mm: ~80%; >4 mm: ~50% | | **Ulceration** | Second most important (universal) | Ulcerated melanoma upstaged; worse prognosis at all T stages | | **Mitotic Rate** | Critical for T1 tumors specifically | ≥1 mitosis/mm² upgrades T1a → T1b; important but NOT universally second after Breslow | | **Lymphocytic Infiltration (TILs)** | Favorable marker | Brisk TIL infiltration is associated with **improved** prognosis | | **Clark Level** | Less used now | Replaced by Breslow thickness in modern staging | ### Why Option D is the EXCEPT Answer **Key Point:** Option D states that "Mitotic rate >10 per mm² is the **most important prognostic factor after Breslow thickness**." This is **inaccurate**. According to the AJCC 8th Edition, **ulceration** is the second most important prognostic factor after Breslow thickness and applies universally across all T stages. Mitotic rate is particularly important for T1 melanomas (used to define T1b), but it is not ranked as the universally second most important factor. **High-Yield:** AJCC 8th Edition prognostic hierarchy: 1. Breslow thickness (most important) 2. Ulceration (second most important — universal) 3. Mitotic rate (especially relevant for T1 tumors) ### Why the Other Options ARE Accurate - **Option A (Brisk TILs = improved prognosis):** Brisk tumor-infiltrating lymphocytes are associated with a **favorable** immune response and improved prognosis in melanoma — this is the current consensus in the literature (Robbins Pathology; AJCC 8th Edition commentary). - **Option B (No ulceration = better prognosis):** Correct — absence of ulceration confers better prognosis; ulceration upstages the tumor. - **Option C (Breslow 4 mm → ~50% 5-year survival):** Correct — melanomas >4 mm (T4) carry approximately 50% 5-year survival. **Clinical Pearl:** The original explanation's claim that brisk TIL infiltration is associated with *worse* prognosis is not supported by current AJCC 8th Edition or mainstream dermatopathology literature (Robbins & Cotran, 10th ed.). Brisk TILs are a favorable prognostic marker. The true EXCEPT answer is Option D, which overstates the role of mitotic rate relative to ulceration. *Reference: AJCC Cancer Staging Manual, 8th Edition; Robbins & Cotran Pathologic Basis of Disease, 10th Edition.*